Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.

Pignolo RJ, Baujat G, Brown MA, De Cunto C, Di Rocco M, Hsiao EC, Keen R, Al Mukaddam M, Sang KLQ, Wilson A, White B, Grogan DR, Kaplan FS.

Orphanet J Rare Dis. 2019 May 3;14(1):98. doi: 10.1186/s13023-019-1068-7. Erratum in: Orphanet J Rare Dis. 2019 May 23;14(1):113.

2.

Fibroplasia Ossificans Progressiva: A Case Report of a Rare Disease Entity.

Solomon D, Wakjira I, Hailu D, Gorfy Y.

Ethiop J Health Sci. 2018 Jul;28(4):513-516. doi: 10.4314/ejhs.v28i4.17.

3.

Simulation-Guided Tracheotomy in a Patient With Fibrodysplasia Ossificans Progressiva.

Padia R, Miller C, Patak L, Friedman SD, Stone K, Otjen J, Johnson K.

Laryngoscope. 2019 Apr;129(4):812-817. doi: 10.1002/lary.27520. Epub 2018 Dec 23.

PMID:
30582158
4.

NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.

Barruet E, Morales BM, Cain CJ, Ton AN, Wentworth KL, Chan TV, Moody TA, Haks MC, Ottenhoff TH, Hellman J, Nakamura MC, Hsiao EC.

JCI Insight. 2018 Nov 15;3(22). pii: 122958. doi: 10.1172/jci.insight.122958.

5.

Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M.

Int J Mol Sci. 2018 Nov 13;19(11). pii: E3586. doi: 10.3390/ijms19113586. Review.

6.

An Adult Zebrafish Model of Fibrodysplasia Ossificans Progressiva.

LaBonty M, Yelick PC.

Methods Mol Biol. 2019;1891:155-163. doi: 10.1007/978-1-4939-8904-1_11.

7.

An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.

Hino K, Zhao C, Horigome K, Nishio M, Okanishi Y, Nagata S, Komura S, Yamada Y, Toguchida J, Ohta A, Ikeya M.

Stem Cell Reports. 2018 Nov 13;11(5):1106-1119. doi: 10.1016/j.stemcr.2018.10.007. Epub 2018 Nov 1.

8.

ACVR1R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification.

Haupt J, Stanley A, McLeod CM, Cosgrove BD, Culbert AL, Wang L, Mourkioti F, Mauck RL, Shore EM.

Mol Biol Cell. 2019 Jan 1;30(1):17-29. doi: 10.1091/mbc.E18-05-0311. Epub 2018 Oct 31.

9.

Morpholino-Mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva.

Maruyama R, Yokota T.

Methods Mol Biol. 2018;1828:497-502. doi: 10.1007/978-1-4939-8651-4_32.

PMID:
30171563
10.

Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells.

Nakajima T, Shibata M, Nishio M, Nagata S, Alev C, Sakurai H, Toguchida J, Ikeya M.

Development. 2018 Aug 23;145(16). pii: dev165431. doi: 10.1242/dev.165431.

11.

My Phenotype speaks: please do not harm me with biopsy needle.

Saini I, Bagri N, Gupta N.

Acta Reumatol Port. 2018 Apr-Jun;43(2):156-158.

12.

Difficult airway management in a child with fibrodysplasia ossificans progressiva in status asthmaticus.

Ojo B, Collins M, Ou H, Rampersad S, Rubens D, Patak L.

J Clin Anesth. 2018 Dec;51:8-9. doi: 10.1016/j.jclinane.2018.07.004. Epub 2018 Jul 21. No abstract available.

PMID:
30036738
13.

Fibrodysplasia Ossificans Progressiva: A Case Report.

Acharya S, Joshi S, Chaulagain R.

J Nepal Health Res Counc. 2018 Jul 4;16(2):245-247.

PMID:
29983445
14.

Severe trismus and contraindicated exodontia in a patient with fibrodysplasia ossificans progressiva: case report.

Geddis-Regan A.

Br J Oral Maxillofac Surg. 2018 Jun;56(5):427-429. doi: 10.1016/j.bjoms.2018.03.021. Epub 2018 May 3.

PMID:
29730069
15.

A Bizarre Bone Scan of Fibrodysplasia Ossificans Progressiva.

Chuang TL, Ho KW, Wang YF.

Clin Nucl Med. 2018 Jun;43(6):433-435. doi: 10.1097/RLU.0000000000002097.

PMID:
29659394
16.

Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.

Pacifici M.

Curr Opin Pharmacol. 2018 Jun;40:51-58. doi: 10.1016/j.coph.2018.03.007. Epub 2018 Mar 31. Review.

17.

The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.

Cappato S, Giacopelli F, Ravazzolo R, Bocciardi R.

Int J Mol Sci. 2018 Mar 26;19(4). pii: E989. doi: 10.3390/ijms19040989. Review.

18.

Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

Machiya A, Tsukamoto S, Ohte S, Kuratani M, Fujimoto M, Kumagai K, Osawa K, Suda N, Bullock AN, Katagiri T.

Bone. 2018 Jun;111:101-108. doi: 10.1016/j.bone.2018.03.015. Epub 2018 Mar 15.

19.

Difficult diagnosis and genetic analysis of fibrodysplasia ossificans progressiva: a case report.

Tian S, Zhu J, Lu Y.

BMC Med Genet. 2018 Feb 27;19(1):30. doi: 10.1186/s12881-018-0543-7.

20.

Fibrodysplasia ossificans progressiva: a current review of imaging findings.

Bauer AH, Bonham J, Gutierrez L, Hsiao EC, Motamedi D.

Skeletal Radiol. 2018 Aug;47(8):1043-1050. doi: 10.1007/s00256-018-2889-5. Epub 2018 Feb 14. Review.

PMID:
29445932

Supplemental Content

Loading ...
Support Center